Round Rock Advisors LLC Purchases New Shares in Omada Health, Inc. $OMDA

Posted by Geri Gentry on Sep 3rd, 2026

Round Rock Advisors LLC acquired a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,932 shares of the company’s stock, valued at approximately $745,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC bought a new stake in Omada Health during the 2nd quarter valued at approximately $637,000. Walleye Capital LLC purchased a new position in shares of Omada Health in the 2nd quarter valued at approximately $458,000. Ilex Capital Partners UK LLP purchased a new stake in Omada Health in the second quarter worth $201,000. Soros Fund Management LLC bought a new position in Omada Health in the second quarter worth $640,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Omada Health during the 2nd quarter valued at $32,000.

Omada Health Stock Up 2.1%

Shares of OMDA stock opened at $23.31 on Thursday. The company has a 50 day moving average price of $22.59 and a 200-day moving average price of $17.46. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The firm has a market capitalization of $1.43 billion, a PE ratio of 466.20 and a beta of 1.86.

Omada Health (NASDAQ:OMDA – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. Analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Morgan Stanley reissued an “overweight” rating and set a $30.00 price target on shares of Omada Health in a research report on Monday, June 22nd. Robert W. Baird raised their target price on shares of Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, Evercore reissued an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $26.50.

Read Our Latest Analysis on OMDA

Insider Activity at Omada Health

In other news, President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $25.02, for a total value of $221,827.32. Following the sale, the president directly owned 307,372 shares of the company’s stock, valued at approximately $7,690,447.44. The trade was a 2.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Craig Gracey sold 1,042 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the completion of the sale, the chief accounting officer owned 15,441 shares in the company, valued at $386,025. This represents a 6.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 255,834 shares of company stock worth $5,398,196. 6.38% of the stock is currently owned by corporate insiders.

Omada Health Company Profile

(Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.